One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.

Lupus can affect patients in many ways, and although no two patients will share exactly the same symptoms, there are some common symptoms that most people know of, like a butterfly rash, joint pain, ...

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

Bridget Gardiner resides in the mountains of Santa Cruz with her two loving teenage sons. She is the founder of the Facebook support community and blog "My Mountain, My Lupus” where she uses stories ...

Damage to the body’s organs from lupus, an autoimmune disorder caused by a patient’s own immune system attacking healthy tissues, can result in a wide range of symptoms, from skin issues to kidney and ...

Each person with lupus is affected differently by the disease, and may experience a unique combination of symptoms. Thus, each treatment regimen for the autoimmune inflammatory disorder will be unique ...

Despite what you’ve read, there is no established diet for lupus. There are certain foods that may improve life while living with lupus, and that are certain foods that can worsen your flares and how ...

Lupus is a chronic disorder wherein the immune system attacks the body’s own healthy tissue. Lupus can affect virtually every part of the body, including the skin, kidneys, joints, brain, heart, and ...

Lupus is an autoimmune disorder wherein the immune system attacks the body’s own healthy tissue. A diagnosis can be challenging as there is no single, definite test available. Furthermore, lupus ...

Lupuzor (rigerimod, or IPP-201101) combined with standard therapy did not demonstrate a statistically significant response rate in systemic lupus erythematosus (SLE) patients over standard care alone, ...

Brepocitinib, an investigational oral therapy, failed to show any benefits beyond a placebo in a Phase 2 clinical trial that tested it in adults with moderate to severely active systemic lupus ...

Ventus Therapeutics plans to develop a new treatment candidate for lupus and other inflammatory diseases marked by the activation of the type 1 interferon immune system pathway, the company recently ...